MedTrace Logo

Longitudinal Analysis of Respiratory and Intestinal Microbiome in Cystic Fibrosis

NCT03335202 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2017-11-17

No results posted yet for this study

Summary

Respiratory und intestinal microbiome will bei analyzed during a period of 6 months. In a retrospective analysis it will be looked for correlations between microbiome and cf therapy (e.g. inhaled and systemic antibiotics, cftr modifiers, proton pump Inhibitors, enzymes, nutritional habits), clinical status and self reported outcome.

Conditions

Interventions

DIAGNOSTIC_TEST

analysis of microbiome

microbial profiling by next generation sequencing

Sponsors & Collaborators

  • University of Kiel

    lead OTHER

Principal Investigators

  • Ingrid CF Bobis, MD · Klinik für Innere Medizin I, UKSH Kiel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-28
Primary Completion
2019-09-30
Completion
2020-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03335202 on ClinicalTrials.gov